Effect of levamisole on cell-mediated immune responses in patients with nasopharyngeal carcinoma.
CMI functions, as monitored by responses in the Mantoux and PHA tests, can be augmented by a short oral course of levamisole. The augmentation is dosage dependent and, in some patients, of long duration.